Why is this a strong buy? Am I wrong or is most of the pipeline failed with failures or remakes or previous failures? This is a cash play but the cash is burning.
AZN made a real bad choice by going into Phase III's based on a relatively small study that was mostly done in India or completely done in India. This drug doesn't work...that is now obvious. And this latest trial was run partially in India and still didn't show any signs of efficacy. This program isn't going to pay out IMO because the next two trials to read out are not even similar...one is very similar to this one and I'm expecting the same results. So far this pipeline is bad news. I think Targacept needs to just scrap the pipeline before they lose the rest of shareholders cash. Clearly, this platform isn't working out. Use our cash to bring in something new and bring it to market. This science is worthless...very obviously.